Search

everythinglearnresearchcommunity

for

Search:↓

Hair changes can indicate systemic diseases or medication effects.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Stem cell treatment improved hair density in female hair loss patient.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

A boy had unusual synchronized hair growth with short active growth phases, not fitting known hair disorders.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Immune cells affect hair growth and could lead to new hair loss treatments.

To prevent and treat Hair-thread tourniquet syndrome in infants, keep a close eye on their limbs, manage maternal hair loss, and educate parents and healthcare providers.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Hair loss peaks in spring and regrowth in late summer, with pregnant females losing the most hair.

COVID-19 infection may cause hair loss.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Cathepsin L is essential for normal hair growth and development.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Placenta products might help with hair loss, but more research is needed.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.